Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats

Pancreas

Volumn 21, Issue 3, 2000, Pages 290-295

  Naruse, Satoru ^a   Wang, Youxue ^a   Kitagawa, Motoji ^a   Ishiguro, Hiroshi ^a   Seki, Yasunaga ^a   Ozaki, Tsuyoshi ^b   Hayakawa, Tetsuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Acute necrotizing pancreatitis; Antibiotics; Bacterial infection; Protease inhibitor; Survival

Indexed keywords

ANTIBIOTIC AGENT; IMIPENEM; NAFAMSTAT MESILATE; PROTEINASE INHIBITOR; SODIUM CHLORIDE; TAUROCHOLIC ACID; TRYPSIN;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFECT; INTESTINE FLORA; MALE; NONHUMAN; PANCREAS NECROSIS; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

ACUTE DISEASE; ANIMALS; BACTERIAL INFECTIONS; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; GUANIDINES; IMIPENEM; MALE; PANCREAS; PANCREATITIS; PROTEASE INHIBITORS; RATS; RATS, WISTAR; SURVIVAL RATE; TAUROCHOLIC ACID; THIENAMYCINS; TRYPSIN;

EID: 0033807063     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200010000-00011     Document Type: Article

References (30)

1. Pathogenesis of acute pancreatitis
2. Interstitial protease activation is the central event in progression to necrotizing pancreatitis
3. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis
4. Trypsinogen-activation peptides in experimental rat pancreatitis: Prognostic implications and histologic correlates
5. Activation of trypsinogen in experimental models of acute pancreatitis in rats
6. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
7. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis
8. Gabexate mesilate in human acute pancreatitis
9. Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis
10. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography
11. Effect of FOY-305 (Camostate) on severe acute pancreatitis in two experimental animal models
12. Effect of a new synthetic trypsin inhibitor on taurocholate-induced acute pancreatitis in rats
13. Bacterial contamination of pancreatic necrosis. A prospective clinical study
14. Early diagnosis of pancreatic infection by computed tomography-guided aspiration
15. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem
16. Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis
17. Antibiotic prophylaxis in the initial management of severe acute pancreatitis
18. New synthetic inhibitors of Clr, Cl esterase, thrombin, plasmin, kallikrein and trypsin
19. Human pancreatic tissue concentration of bactericidal antibiotics
20. Segmental division of the rat pancreas for experimental procedures
21. Effects of a bradykinin receptor antagonist (HOE140) on taurocholate-induced acute pancreatitis in rats
22. Monitoring serum tryic activity and effect of trypsin inhibitor on rat acute pancreatitis
23. Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis
24. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases
25. The role of the gut in the development of sepsis in acute pancreatitis
26. Time course of bacterial infection of the pancreas and its relation to disease severity in a rodent model of acute necrotizing pancreatitis
27. Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis
28. Pancreatic atrophy follows bile-induced acute pancreatitis in the rat
29. Therapeutic regimens in acute experimental pancreatitis in rats: Effects of a protease inhibitor, a β-agonist, and antibiotics
30. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis